Literature DB >> 24179428

Nutritional differences in neurologically impaired children.

Alura Riley1, Christina Vadeboncoeur.   

Abstract

OBJECTIVES: To determine whether the recommended nutritional intake of moderately to severely neurologically impaired children is congruent with current growth parameter expectations.
METHODS: Observational cross-sectional study at a children's hospice and a tertiary care children's hospital. Medically stable enterally fed children followed by the palliative care team underwent anthropometric assessment and chart review for diagnosis, intake and medications. Intakes, guidelines and recommendations were compared.
RESULTS: Intakes were less than recommended. All children were <50th percentile weight-for-age, with many <3rd percentile. Fourteen of 15 were in higher percentiles for absolute and relative body fat.
CONCLUSIONS: Recommended dietary intakes were not achieved by these children. Despite this, measures of body fat indicate adequate intake. Low weight values may reflect diagnosis-related growth stunting or decreased muscle mass and bone density from immobility. The Centers for Disease Control and Prevention (Georgia, USA) weight-for-age and body mass index are not suitable measures of adequate intake in this group of children.

Entities:  

Keywords:  Enteral; Neurological impairment; Nutrition; Pediatric palliative care

Year:  2012        PMID: 24179428      PMCID: PMC3496364          DOI: 10.1093/pch/17.9.e98

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  26 in total

1.  Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children.

Authors:  K G Tolman; W Jubiz; J J Sannella; J A Madsen; R E Belsey; R S Goldsmith; J W Freston
Journal:  Pediatrics       Date:  1975-07       Impact factor: 7.124

2.  Growth response to enteral feeding by children with cerebral palsy.

Authors:  K D Sanders; K Cox; R Cannon; D Blanchard; J Pitcher; P Papathakis; L Varella; R Maughan
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Jan-Feb       Impact factor: 4.016

3.  Densitometric and quantitative ultrasound measurements and laboratory investigations in wheelchair-bound patients.

Authors:  Wojciech Pluskiewicz; Bogna Drozdzowska; Anita Lyssek-Boroń; Tomasz Bielecki; Piotr Adamczyk; Przemysław Sawaryn; Maciej Misolek
Journal:  J Clin Densitom       Date:  2006-03-29       Impact factor: 2.617

Review 4.  What does the epidemic of childhood obesity mean for children with special health care needs?

Authors:  Paula M Minihan; Sarah N Fitch; Aviva Must
Journal:  J Law Med Ethics       Date:  2007       Impact factor: 1.718

Review 5.  Nutrition support for neurologically impaired children: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Valerie Marchand; Kathleen J Motil
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-07       Impact factor: 2.839

6.  Assessment of linear growth of children with cerebral palsy: use of alternative measures to height or length.

Authors:  Q W Spender; C E Cronk; E B Charney; V A Stallings
Journal:  Dev Med Child Neurol       Date:  1989-04       Impact factor: 5.449

7.  Weight and length increases in children after gastrostomy placement.

Authors:  D S Corwin; J S Isaacs; K E Georgeson; A A Bartolucci; H H Cloud; C B Craig
Journal:  J Am Diet Assoc       Date:  1996-09

8.  Dietary considerations in osteopenia in tube-fed nonambulatory children with cerebral palsy.

Authors:  B Duncan; L L Barton; J Lloyd; M Marks-Katz
Journal:  Clin Pediatr (Phila)       Date:  1999-03       Impact factor: 1.168

9.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

10.  Undernutrition in children with a neurodevelopmental disability. Nutrition Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1994-09-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.